Obesity Management Market

Obesity Management Market: Phentermine and Topiramate Expected to be the Second Most Lucrative Segment by Drug Type: Global Industry Analysis and Opportunity Assessment 2017-2027

  • 2017-05-03
  • REP-GB-587
  • 177 pages
  • PDF PPT EXCEL
Obesity Management Market

An Incisive, In-depth Analysis on the Obesity Management Market

This study offers a comprehensive, 360 degree analysis on the Obesity Management market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global Obesity Management market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.

Increasing life expectancy and worsening lifestyle to blame for obesity

Lifestyle diseases such as diabetes and other chronic ailments are the main cause of obesity around the world. Improved healthcare and medical facilities have led to an increase in the life expectancy of people, which is the primary reason for the large geriatric population seen in the developed world. Geriatric people are far more prone to conceal sarcopenia i.e. a noticeable rise in body fat with simultaneous loss of muscle mass and functional capability. This makes them the main segment of the global obesity management market in both the short and the long term.

Side effects and safety issues a big concern in the obesity management market

Even though the number of obesity drug users that are on anti-obesity therapeutic drugs are rising every day on account of their enormous benefits, a few studies have demonstrated adverse side effects when these drugs are taken in the long term. The same study also shows diabetes, high cholesterol, heart disease, high blood pressure, sleep apnea, asthma, cancer, depression and strokes to be linked to obesity drugs. These somewhat conflicting findings on the obesity management market have left both medical professionals and patients confused about the purported benefits and they have become quite wary of the potential side effects. These legitimate safety concerns could easily impede the growth of the global obesity management market.

The obesity management market should grow as obesity is too big a condition to ignore

The prevalence of obesity has nearly doubled in the years since 1980. In 2014, more than half a billion people were obese and almost 2 billion adults were overweight i.e. 13% of the global population is obese and 39% are overweight. Nearly 3 million people die every year as a result of being overweight or obese. Obesity accounts for approximately half of Type 2 diabetes cases across the globe. Obesity is the fifth leading factor responsible for death and this affects not only developed nations, but also developing countries. In the U.S, the obese population was roughly 40% and the overweight population was nearly 70% of the entire population in 2014. Hence, weight loss and obesity management plays an important role to make sure that these chronic disease like diabetes, high blood pressure, high cholesterol, heart disease can be controlled to lead a healthy life.  All these factors should spur the growth of the global obesity management market during the course of the forecast period.

Bupropion and Naltrexone drug type segment anticipated to witness the highest CAGR

While Orlistat dominates the global obesity management market by drug type at present with an estimated market value of more than US$ 200 Mn in 2017, it is poised to record the lowest CAGR of only 1.5% during the decade 2017-2027. On the other hand, Bupropion and Naltrexone is predicted to grow at a massive 8.3% CAGR for the decade, pushing it to a market value of nearly US$ 109 Mn by 2027, as opposed to just under US$ 46 Mn in 2016. An absolute dollar opportunity of roughly US$ 3.6 Mn can be reasonably expected in the Bupropion and Naltrexone segment of the global obesity management market in 2018 over the previous year.

obesity management market

North America alone is expected to account for 1/3rd of the global obesity management market

North America is forecast to account for more than 1/3rd revenue share of the global obesity management market by 2017 and it should gain a substantial 224 BPS by the year 2027. The Bupropion and Naltrexone drug segment in the North America obesity management market is estimated to be worth around US$ 13.6 Mn in 2017 and this is assumed to rise to slightly under US$ 32 Mn by 2027, as a result of a high CAGR of 8.9%. As with the global obesity management market, the CAGR in the North America obesity management market is highest in the Bupropion and Naltrexone segment, making it highly attractive to key stakeholders.

About the Publication

Obesity is one of the most evil scourges of our modern day sedentary lifestyle. It is extremely common in certain countries in the developed world and has even begun spreading its tentacles into developing countries. In our report, ‘Obesity Management Market: Global Industry Analysis and Opportunity Assessment 2017–2027’, we at Future Market Insights have taken an in-depth look at the global obesity management market as these devices will prove invaluable in tackling the pressing health challenges the globe faces today. With the help of several important metrics, our analysts have given their expert opinion on current and future trends that can be reasonably assumed to occur in the global obesity management market.

The global obesity management market report begins with an executive summary that gives a succinct yet comprehensive first glance at the global obesity management market. The executive summary includes the global obesity management market size by region for both the years 2017 and 2027, market share and the market value by region, treatment type and distribution channel type. All of these have been provided in an easy-to-understand, attractive graphical format for our readers’ convenience. The executive summary also includes a market approach to be adopted, the major segment and countries or regions to target with a differentiating strategy to succeed with flying colours in the global obesity management market. The executive summary is complemented by an introduction to the global obesity management market where we have given a lucid definition of obesity with a few relevant statistics that reveal how much of a challenge obesity truly is on a global scale. We have relied on data from the World Health Organization as an authoritative source of information.

The next section of the global obesity management market report focusses on the market analysis. This is where have touched upon the global obesity management market size and the Y-o-Y growth that can be anticipated over the duration of the forecast period, along with the absolute dollar opportunity that can be tapped. A few of the key takeaways are mentioned below the graphs for your quick perusal, which we would highly recommend you to glance at while referring to this section.

To understand the global obesity management market, it would be extremely helpful to observe the overall market dynamics beforehand and that is the precise purpose of this section of the global obesity management market report. We have highlighted the macro-economic factors that can have an impact on the global obesity management market, the drivers that can boost the market from both the demand as well as the supply side, along with the restraints that could impede market growth. The trends and opportunities that key stakeholders can expect in the global obesity management market, the relevance and impact of certain forecast factors and the scenario forecast provide a holistic approach to the global obesity management market. The guidelines laid down by relevant regulatory bodies have to be extremely stringent and of the highest standard as any mistake or negligence could prove very costly and could even result in loss of life. The regulations of the U.S FDA and the European Medicine Agency have been detailed in the report. In addition to this, we have briefly spoken about the drugs that are in the pipeline in the global obesity management market. An epidemiology analysis concludes this vital section of the global obesity management market report.

In the market analysis and forecast scenario section, we have studied the global obesity management market on the basis of its taxonomy. The Basis Point Share analysis, Y-o-Y growth projections, the market value forecast and the market attractiveness for the drug type, surgery type and distribution channels is mentioned. This can be beneficial for any potential stakeholder who wishes to selectively target certain sections of the global obesity management market. We have divided the global obesity management market into seven regions. Each region has its own dedicated section, where we have detailed the basis point share and Y-o-Y growth projections at a regional level. The market value forecast for the most important countries can assist potential market entrants decide which part of the global obesity management market they wish to focus their resources on.

By Treatment Type By Distribution Channel By Region
  • Drug

    • Bupropion and Naltrexone

    • Orlistat

    • Lorcaserin

    • Phentermine and Topiramate

    • Liraglutide

  • Surgery

    • Gastric Bypass

    • Adjustable Gastric Banding

    • Gastric Sleeve

    • Duodenal Switch

    • Intragastric Balloon Treatment

  • Hospitals

  • Speciality Clinics

  • Ambulatory Surgical Centres

  • Retail Pharmacies

  • North America

  • Western Europe

  • Eastern Europe

  • APEJ

  • Japan

  • Latin America

  • MEA


Along with the regional analysis, it would be advisable to look at what the competition has planned to formulate your own approach in the global obesity management market. We have profiled six renowned companies actively involved in the global obesity management market towards this objective. The company details, key financials, product overview, revenue growth, operating margins and industry classification codes provide you with all the information that you could possibly need. A SWOT analysis and major developments pertaining to the competition completes this critical section of the global obesity management market report.

Research Methodology

The research methodology developed by Future Market Insights is easily one of the best in the industry. Our analysts begin by conducting extensive primary and secondary research to gather adequate data pertaining to the global obesity management market. Data so obtained is validated using the triangulation method. The final data is then thoroughly scrutinised using advanced, proprietary tools to obtain the necessary insights into the global obesity management market.

Obesity Management Market Reports - Table of Contents

Get in touch

Harish Tiwari

Harish Tiwari

Global Head - Business Development

Pranay Mhaisekar

Pranay Mhaisekar

Business Development

* indicates mandatory fields.

Our Clients


CASE STUDIES

See how our work makes an impact.

At FMI, we design strategies that are adaptive, impactful, and implementable.

Request Sample Ask An Analyst Request Special Price Request Methodology